Literature DB >> 12094551

DNA topoisomerase II as a target for cancer chemotherapy.

Jerrylaine V Walker1, John L Nitiss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12094551     DOI： 10.1081/cnv-120002156

Source DB:  PubMed          Journal:  Cancer Invest        ISSN： 0735-7907            Impact factor:   2.176


× No keyword cloud information.
  41 in total

1.  Endonucleolytic processing of covalent protein-linked DNA double-strand breaks.

Authors:  Matthew J Neale; Jing Pan; Scott Keeney
Journal:  Nature       Date:  2005-08-18       Impact factor: 49.962

Review 2.  Targeting DNA topoisomerase II in cancer chemotherapy.

Authors:  John L Nitiss
Journal:  Nat Rev Cancer       Date:  2009-04-20       Impact factor: 60.716

3.  Translational control of TOP2A influences doxorubicin efficacy.

Authors:  Subramanya Srikantan; Kotb Abdelmohsen; Eun Kyung Lee; Kumiko Tominaga; Sarah S Subaran; Yuki Kuwano; Ritu Kulshrestha; Rohit Panchakshari; Hyeon Ho Kim; Xiaoling Yang; Jennifer L Martindale; Bernard S Marasa; Mihee M Kim; Robert P Wersto; Fred E Indig; Dipanjan Chowdhury; Myriam Gorospe
Journal:  Mol Cell Biol       Date:  2011-07-18       Impact factor: 4.272

4.  Convection-enhanced delivery of etoposide is effective against murine proneural glioblastoma.

Authors:  Adam M Sonabend; Arthur S Carminucci; Benjamin Amendolara; Mukesh Bansal; Richard Leung; Liang Lei; Ronald Realubit; Hai Li; Charles Karan; Jonathan Yun; Christopher Showers; Robert Rothcock; Jane O; Andrea Califano; Peter Canoll; Jeffrey N Bruce
Journal:  Neuro Oncol       Date:  2014-03-16       Impact factor: 12.300

5.  Nanogel-mediated delivery of a cocktail of epigenetic drugs plus doxorubicin overcomes drug resistance in breast cancer cells.

Authors:  Sivakumar Vijayaraghavalu; Vinod Labhasetwar
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

6.  Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase II.

Authors:  Lisa M Oppegard; Andrei V Ougolkov; Doris N Luchini; Renee A Schoon; John R Goodell; Harneet Kaur; Daniel D Billadeau; David M Ferguson; Hiroshi Hiasa
Journal:  Eur J Pharmacol       Date:  2008-12-03       Impact factor: 4.432

7.  (-)-Epigallocatechin gallate, a major constituent of green tea, poisons human type II topoisomerases.

Authors:  Omari J Bandele; Neil Osheroff
Journal:  Chem Res Toxicol       Date:  2008-02-23       Impact factor: 3.739

8.  The efficacy of topoisomerase II-targeted anticancer agents reflects the persistence of drug-induced cleavage complexes in cells.

Authors:  Omari J Bandele; Neil Osheroff
Journal:  Biochemistry       Date:  2008-10-16       Impact factor: 3.162

9.  Cleavage of plasmid DNA by eukaryotic topoisomerase II.

Authors:  Omari J Bandele; Neil Osheroff
Journal:  Methods Mol Biol       Date:  2009

10.  Bioflavonoids as poisons of human topoisomerase II alpha and II beta.

Authors:  Omari J Bandele; Neil Osheroff
Journal:  Biochemistry       Date:  2007-04-26       Impact factor: 3.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.